A Pilot Study -- An Open-Label, Rater-blinded, Flexible-dose, 8-week Trial of Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features.
Phase of Trial: Phase III
Latest Information Update: 30 May 2013
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Mar 2008 New trial record.